TRAF6 mediates IL-1β/LPS-induced suppression of TGF-β signaling through its interaction with the type III TGF-β receptor

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Lim, Seunghwan ^a   Bae, Eunjin ^b,c   Kim, Hae Suk ^a   Kim, Tae Aug ^d   Byun, Kyunghee ^c   Kim, Byungchul ^e   Hong, Suntaek ^c   Im, Jong Pil ^a,f   Yun, Chohee ^a   Lee, Bona ^a,b   Lee, Bonghee ^c   Park, Seok Hee ^g   Letterio, John ^a   Kim, Seong Jin ^a,b,c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHA University   (South Korea)

^c Gachon University   (South Korea)

^d NATIONAL CANCER INSTITUTE   (United States)

^e Kangwon National University   (South Korea)

^f Seoul National University College of Medicine   (South Korea)

^g Sungkyunkwan University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ARRESTIN 1; BETA ARRESTIN 2; INTERLEUKIN 1BETA; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA3; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; LIPOPOLYSACCHARIDE; PROTEOGLYCAN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3;

ARTICLE; BINDING AFFINITY; CELL GROWTH; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; POINT MUTATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; TUMOR GROWTH; ANIMAL; CELL FRACTIONATION; DNA FRAGMENTATION; FLUORESCENCE MICROSCOPY; GENE SILENCING; GENETICS; IMMUNOLOGY; INFLAMMATION; METABOLISM; MOUSE; NICK END LABELING; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS;

ANIMALS; CELL FRACTIONATION; DNA FRAGMENTATION; GENE KNOCKDOWN TECHNIQUES; IN SITU NICK-END LABELING; INFLAMMATION; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MICE; MICROSCOPY, FLUORESCENCE; MUTAGENESIS, SITE-DIRECTED; PROTEOGLYCANS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 6; TRANSFORMING GROWTH FACTOR BETA;

EID: 84863271183     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032705     Document Type: Article

References (34)

1. Letterio JJ, Roberts AB, (1996) Transforming growth factor-β1-deficient mice: identification of isoform-specific activities in vivo. J Leukoc Biol 59: 769-774.
2. ten Dijke P, Hill CS, (2004) New insights into TGF-β-Smad signalling. Trends Biochem Sci 29: 265-273.
3. Blobe GC, Schiemann WP, Lodish HF, (2000) Role of transforming growth factor β in human disease. N Engl J Med 342: 1350-1358.
4. Dong M, How T, Kirkbride KC, Gordon KJ, Lee JD, et al. (2007) The type III TGF-β receptor suppresses breast cancer progression. J Clin Invest 117: 206-217.
5. Chen W, Kirkbride KC, How T, Nelson CD, Mo J, et al. (2003) β-arrestin 2 mediates endocytosis of type III TGF-β receptor and down-regulation of its signaling. Science 301: 1394-1397.
6. Karin M, (2006) Nuclear factor-κB in cancer development and progression. Nature 441: 431-436.
7. Karin M, Cao Y, Greten FR, Li ZW, (2002) NF-κB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2: 301-310.
8. Coussens LM, Werb Z, (2002) Inflammation and cancer. Nature 420: 860-867.
9. Choi KC, Lee YS, Lim S, Choi HK, Lee CH, et al. (2006) Smad6 negatively regulates interleukin 1-receptor-Toll-like receptor signaling through direct interaction with the adaptor Pellino-1. Nat Immunol 7: 1057-1065.
10. Hong S, Lim S, Li AG, Lee C, Lee YS, et al. (2007) Smad7 binds to the adaptors TAB2 and TAB3 to block recruitment of the kinase TAK1 to the adaptor TRAF2. Nat Immunol 8: 504-513.
11. Roman-Blas JA, Stokes DG, Jimenez SA, (2007) Modulation of TGF-β signaling by proinflammatory cytokines in articular chondrocytes. Osteoarthritis Cartilage 15: 1367-1377.
12. Benus GF, Wierenga AT, de Gorter DJ, Schuringa JJ, van Bennekum AM, et al. (2005) Inhibition of the transforming growth factor beta (TGFβ) pathway by interleukin-1β is mediated through TGFbeta-activated kinase 1 phosphorylation of SMAD3. Mol Biol Cell 16: 3501-3510.
13. Bitzer M, von Gersdorff G, Liang D, Dominguez-Rosales A, Beg AA, et al. (2000) A mechanism of suppression of TGF-β/SMAD signaling by NF-κB/RelA. Genes Dev 14: 187-197.
14. Walsh MC, Kim GK, Maurizio PL, Molnar EE, Choi Y, (2008) TRAF6 autoubiquitination-independent activation of the NFκB and MAPK pathways in response to IL-1 and RANKL. PLoS One 3: e4064.
15. Chen ZJ, (2005) Ubiquitin signalling in the NF-κB pathway. Nat Cell Biol 7: 758-765.
16. Kim BC, Mamura M, Choi KS, Calabretta B, Kim SJ, (2002) Transforming growth factor β 1 induces apoptosis through cleavage of BAD in a Smad3-dependent mechanism in FaO hepatoma cells. Mol Cell Biol 22: 1369-1378.
17. Guttridge DC, Albanese C, Reuther JY, Pestell RG, Baldwin AS Jr, (1999) NF-κB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol 19: 5785-5799.
18. Lopez-Casillas F, Wrana JL, Massague J, (1993) Betaglycan presents ligand to the TGF βsignaling receptor. Cell 73: 1435-1444.
19. Wang Y, Tang Y, Teng L, Wu Y, Zhao X, et al. (2006) Association of β-arrestin and TRAF6 negatively regulates Toll-like receptor-interleukin 1 receptor signaling. Nat Immunol 7: 139-147.
20. Soderberg O, Gullberg M, Jarvius M, Ridderstrale K, Leuchowius KJ, et al. (2006) Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat Methods 3: 995-1000.
21. Fredriksson S, Gullberg M, Jarvius J, Olsson C, Pietras K, et al. (2002) Protein detection using proximity-dependent DNA ligation assays. Nat Biotechnol 20: 473-477.
22. Han SU, Kwak TH, Her KH, Cho YH, Choi C, et al. (2008) CEACAM5 and CEACAM6 are major target genes for Smad3-mediated TGF-β signaling. Oncogene 27: 675-683.
23. Moon JA, Kim HT, Cho IS, Sheen YY, Kim DK, (2006) IN-1130, a novel transforming growth factor-β type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy. Kidney Int 70: 1234-1243.
24. Sorrentino A, Thakur N, Grimsby S, Marcusson A, von Bulow V, et al. (2008) The type I TGF-β receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner. Nat Cell Biol 10: 1199-1207.
25. Blobe GC, Schiemann WP, Pepin MC, Beauchemin M, Moustakas A, et al. (2001) Functional roles for the cytoplasmic domain of the type III transforming growth factor β receptor in regulating transforming growth factor beta signaling. J Biol Chem 276: 24627-24637.
26. Hahm KB, Im YH, Parks TW, Park SH, Markowitz S, et al. (2001) Loss of transforming growth factor β signalling in the intestine contributes to tissue injury in inflammatory bowel disease. Gut 49: 190-198.
27. Im YH, Kim HT, Kim IY, Factor VM, Hahm KB, et al. (2001) Heterozygous mice for the transforming growth factor-β type II receptor gene have increased susceptibility to hepatocellular carcinogenesis. Cancer Res 61: 6665-6668.
28. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, et al. (2000) Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404: 398-402.
29. Macarthur M, Hold GL, El-Omar EM, (2004) Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am J Physiol Gastrointest Liver Physiol 286: G515-520.
30. Voronov E, Shouval DS, Krelin Y, Cagnano E, Benharroch D, et al. (2003) IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci U S A 100: 2645-2650.
31. Gatza CE, Oh SY, Blobe GC, (2010) Roles for the type III TGF-β receptor in human cancer. Cell Signal 22: 1163-1174.
32. Cejas PJ, Walsh MC, Pearce EL, Han D, Harms GM, et al. (2010) TRAF6 inhibits Th17 differentiation and TGF-βmediated suppression of IL-2. Blood 115: 4750-4757.
33. Yamashita M, Fatyol K, Jin C, Wang X, Liu Z, et al. (2008) TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-β. Mol Cell 31: 918-924.
34. Lee BH, Kim MS, Rhew JH, Park RW, de Crombrugghe B, et al. (2000) Transcriptional regulation of fibronectin gene by phorbol myristate acetate in hepatoma cells: a negative role for NF-κB. J Cell Biochem 76: 437-451.